COVID-19 Evidence Reviews
as of 8/13/20
menu
 
 

VA ESP Reviews
 
= living review
= draft/preprint   |  
= meets mimimum quality standards   |  

A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
latest update
report
select
7/27/20
Goldstein KM, Ghadimi K, Mystakelis H, et al. | VA Evidence Synthesis Program
Aim: To review the evidence on the risk of transmitting SARS-CoV-2, SARS, MERS, and influenza with administration of drugs via nebulizer
UPDATED
VA ESP
7/20/20
 | VA Evidence Synthesis Program
VA ESP
7/20/20
 | VA Evidence Synthesis Program
VA ESP
7/10/20
Lewis J, Mackey K | VA Evidence Synthesis Program
Aim: To critically appraise the identified study and provide additional context for study findings.
VA ESP
6/26/20
Helfand M | VA Evidence Synthesis Program
Aim: To review the evidence for using corticosteroids to treat acute respiratory distress syndrome in patients with COVID-19.
UPDATED
VA ESP
6/26/20
Duan-Porter W | VA Evidence Synthesis Program
Aim: To explore the length of stay in the intensive care unit (ICU) and time on invasive mechanical ventilation for adult patients with COVID-19.
UPDATED
VA ESP
6/20/20
Maldonado E, Tao D, Mackey K | J Gen Intern Med
Aim: To synthesize evidence on thromboembolism incidence and outcomes with antithrombotic therapies in COVID-19.
UPDATED
VA ESP
CANDIDATE THERAPEUTICS
6/19/20
Ayers C, Kondo K, Saha S, et al | VA Evidence Synthesis Program
VA ESP
5/18/20
Mackey K, King VJ, Gurley S, et al. | VA Evidence Synthesis Program
Aim: To synthesize evidence on the role of ACE inhibitor and ARB use on patient outcomes in COVID-19 as well as evidence on the benefits and harms of initiating these medications to treat patients with COVID-19.
UPDATED
WHO COLLABORATIVE
VA ESP
5/15/20
Lindquist I, Mackey K, Edwards S | VA Evidence Synthesis Program
Aim: To provide author feedback and critical appraisal in a similar manner as would be provided by editorial staff of a journal.
VA ESP